RJA
OBCI

Raymond James & Associates’s Ocean Bio-Chem Inc OBCI Stock Holding History

Raymond James & Associates’s Portfolio OBCI Stock Details OBCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-21,906
Closed -$314K – 3919
2020
Q3 		$314K Sell
21,906
-5,191
-19% -$78.6K ﹤0.01% 2932
2020
Q2 		$378K Buy
27,097
+11,878
+78% +$79.2K ﹤0.01% 2786
2020
Q1 		$74K Buy
+15,219
New +$57.4K ﹤0.01% 3267

Other funds holding OBCI

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Raymond James & Associates's OBCI Position: Q4 2020 in Review

Raymond James & Associates sold out of Ocean Bio-Chem Inc (OBCI) in Q4 2020, closing a stake of 21,906 shares — an estimated $314K sold.

Raymond James & Associates first reported a position in OBCI in Q1 2020 and held it in 3 quarters. The position peaked at $378K in Q2 2020. 27 funds tracked by Wall St. Rank hold OBCI as of Q4 2020.

  • Raymond James & Associates reported no remaining Ocean Bio-Chem Inc position as of Q4 2020 after selling out during the quarter.
  • Raymond James & Associates sold 21,906 Ocean Bio-Chem Inc shares in Q4 2020, an estimated $314K.
  • Raymond James & Associates first reported a position in Ocean Bio-Chem Inc in Q1 2020 and held it in 3 quarters.
  • Raymond James & Associates's Ocean Bio-Chem Inc position peaked at $378K in Q2 2020.
  • 27 funds tracked by Wall St. Rank held Ocean Bio-Chem Inc as of Q4 2020.

Based on Raymond James & Associates's 13F filing for Q4 2020, filed 12 Feb 2021.